{
    "nctId": "NCT00769821",
    "briefTitle": "The Impact of Lymphedema on Breast Cancer Survivors",
    "officialTitle": "The Impact of Lymphedema on Local and Overall Functioning",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Cancer Survivor, Lymphedema, Perioperative/Postoperative Complications",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 145,
    "primaryOutcomeMeasure": "Degree of lymphedema as assessed by the Norman Questionnaire, Jane M. Armer's Lymphedema and Breast Cancer Questionnaire, arm circumference, and bioimpedance spectroscopy (BIS)",
    "eligibilityCriteria": "DISEASE CHARACTERISTICS:\n\n* Diagnosis of breast cancer\n\n  * No breast cancer on both sides\n  * No recurrence of breast cancer (local or distant)\n* Completed active treatment for breast cancer (i.e., surgery and/or radiotherapy and/or chemotherapy) for \u2265 6 months\n\n  * No prior contralateral or bilateral mastectomy\n* No pre-existing lymphedema prior to breast cancer diagnosis\n* Hormone receptor status not specified\n\nPATIENT CHARACTERISTICS:\n\n* Menopausal status not specified\n* Weight \\< 300 pounds\n* Mentally and physically able to participate\n* No current infection or lymphangitis involving the affected arm\n* No pre-existing neuromuscular conditions that would affect local upper extremity or overall health-related functioning\n* No contraindications to bioimpedance spectroscopy (BIS) testing, including the application of electrode adhesive pads to the skin (i.e., unable to lie supine, allergy to electrode adhesive pads, have sunburn, or have open wound)\n* No contraindications to exercise testing as outlined by the American Heart Association and the American College of Sports Medicine\n\nPRIOR CONCURRENT THERAPY:\n\n* See Disease Characteristics",
    "sex": "FEMALE",
    "minimumAge": "21 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}